Four of them are from China. Work has even begun on a plant capable of producing 100 million doses a year. On Tuesday, Anvisa said it would maintain the suspension and did not give any indication of how long it might last, adding it required more information on the incident. Speaking at the same news conference, he said he hoped the trial would be resumed later on Tuesday or Wednesday. REUTERS/Thomas Peter/File PhotoBrazilian medical institute Butantan said in a statement it would restart trials later on Wednesday.
Anvisa is capable of producing 4 million vaccines a year.
( z0 capable :ARG1 ( z1 product :name ( z2 name :op "Anvisa" ) ) :ARG2 ( z3 produce :ARG0 z1 :ARG1 ( z4 rate-entity :ARG1 ( z5 vaccine :quant 4000000 ) :ARG2 ( z6 temporal-quantity :quant 1 :unit ( z7 year ) ) ) ) )
(z0 / capable-01
    :ARG1 (z1 / product
              :name (z2 / name
                        :op1 "Anvisa"))
    :ARG2 (z3 / produce-01
              :ARG0 z1
              :ARG1 (z4 / rate-entity-91
                        :ARG1 (z5 / vaccine
                                  :quant 4000000)
                        :ARG2 (z6 / temporal-quantity
                                  :quant 1
                                  :unit (z7 / year)))))
Anvisa is capable of producing 4 million vaccines a year .
z1 :name z2
z2 :op1 2
z0 :ARG1 z1
z0 :ARG2 z3
z3 :ARG0 z1
z5 :quant 1
z4 :ARG1 z5
z3 :ARG1 z4
z4 :ARG2 z6
z6 :unit z7
z6 :quant 0